The OTC industry reference guide that no international Consumer Healthcare company should be without.
Published in June each year, IMS OTCreview is the OTC industry reference guide that no international Consumer Healthcare company should be without.It is an unrivalled and hugely detailed publication stretching to over 1,500 pages of audited sales data, background regulatory information, company analyses and market-place dynamics. It also include forecasts of future market activity for the next 5 years.
Individual country chapters are divided into two sections. The Regulatory Environment examines product registration, advertising regulations, distribution, reimbursement, pricing, and Rx-to-OTC switching activity.
For most countries, the 'Market Place' section then uses audited sales data to assess the leading categories, products and companies within the country.
The 'Overview' section contains World and Regional rankings, country forecasts, analyses of the world's leading OTC companies, and a highly insightful summary of the important trends at a global and regional level. This section is vital reading for any senior executive in the OTC industry.
New / Changed / Key Features for 2005
- Enhanced market-place detail for Japan & USA based on data from our new data partner - ACNielsen.
- Expanded market-place detail for Canada.
- Summary market-place country chapter for China based on audited sales data from IMS-URC.
- Sales split by distribution channels for Germany, NL, UK & USA.
Delivery Format
- 6 Hard copy volumes (5 regional sections and the Overview)
